Efficacy of a Continuous GLP-1 Infusion Compared With a Structured Insulin Infusion Protocol to Reach Normoglycemia in Nonfasted Type 2 Diabetic Patients: A Clinical Pilot Trial

OBJECTIVE: Continuously administered insulin is limited by the need for frequent blood glucose measurements, dose adjustments, and risk of hypoglycemia. Regimens based on glucagon-like peptide 1 (GLP-1) could represent a less complicated treatment alternative. This alternative might be advantageous...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sourij, Harald, Schmölzer, Isabella, Kettler-Schmut, Eva, Eder, Michaela, Pressl, Helga, deCampo, Antonella, Wascher, Thomas C.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2009
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2732139/
https://ncbi.nlm.nih.gov/pubmed/19528368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-0475
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars